5.16
Aura Biosciences Inc stock is traded at $5.16, with a volume of 233.21K.
It is down -0.39% in the last 24 hours and down -19.75% over the past month.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
See More
Previous Close:
$5.18
Open:
$5.13
24h Volume:
233.21K
Relative Volume:
1.02
Market Cap:
$327.68M
Revenue:
-
Net Income/Loss:
$-76.41M
P/E Ratio:
-2.6875
EPS:
-1.92
Net Cash Flow:
$-64.56M
1W Performance:
-6.01%
1M Performance:
-19.75%
6M Performance:
-21.34%
1Y Performance:
-37.23%
Aura Biosciences Inc Stock (AURA) Company Profile
Name
Aura Biosciences Inc
Sector
Industry
Phone
(617)500-8864
Address
80 GUEST STREET, BOSTON
Compare AURA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
AURA
Aura Biosciences Inc
|
5.16 | 328.95M | 0 | -76.41M | -64.56M | -1.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Aura Biosciences Inc Stock (AURA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-26-25 | Resumed | Evercore ISI | Outperform |
| May-28-25 | Resumed | H.C. Wainwright | Buy |
| Jul-25-24 | Initiated | H.C. Wainwright | Buy |
| Jul-27-23 | Initiated | Scotiabank | Sector Outperform |
| Apr-17-23 | Resumed | BTIG Research | Buy |
| Jul-19-22 | Initiated | JMP Securities | Mkt Outperform |
View All
Aura Biosciences Inc Stock (AURA) Latest News
Bank Watch: Can Hapag Lloyd Aktiengesellschaft HLAG stock resist broad market declinesTrade Volume Summary & Weekly High Potential Alerts - moha.gov.vn
Aug Breakouts: Why Aura Biosciences Inc stock is popular among millennialsDollar Strength & Expert Curated Trade Ideas - moha.gov.vn
FTAM (Ind) Pvt. Ltd. Moves Into Overbought Range Analysts CautiousPrice Volatility Patterns & Free Daily Stock Hotspot Analysis - bollywoodhelpline.com
SPV Global Trading Limited (512221)’s Trend in 2025VWAP Trading Strategies & Free Stock Index Interpretations - bollywoodhelpline.com
Chart Patterns Forming a Bullish Setup in Service Care LimitedInsider Trading Activity & Invest With Confidence - bollywoodhelpline.com
How (AURA) Movements Inform Risk Allocation Models - Stock Traders Daily
Permanent Capital Management LP Makes New Investment in Aura Biosciences, Inc. $AURA - Defense World
Investors Hope for Bounce in Vinyas Innovative Technologies Limited After SelloffAnalyst Downgrades & High Yield Trading Growth - bollywoodhelpline.com
How Aura Biosciences Inc. stock performs in rising dollar environmentConsumer Goods Stocks & Rapid Portfolio Investment - bollywoodhelpline.com
Aura Biosciences Earnings Notes - Trefis
Aug Patterns: What margin trends mean for Aura Biosciences Inc. stockTrade Exit Report & Long-Term Growth Plans - Улправда
Why Aura Biosciences Inc. stock remains resilient2025 Biggest Moves & AI Forecast Swing Trade Picks - Улправда
Why Aura Biosciences Inc. stock is recommended by analystsJuly 2025 Rallies & Daily Volume Surge Signals - Улправда
What margin trends mean for Aura Biosciences Inc. stock2025 Price Targets & Long-Term Growth Stock Strategies - Улправда
Can Aura Biosciences Inc. stock continue upward trendGap Down & Real-Time Buy Zone Alerts - Улправда
Downgrade Watch: Why Aura Biosciences Inc. stock is recommended by analystsJuly 2025 Rallies & Weekly Market Pulse Alerts - Улправда
Market Pulse: How Aura Biosciences Inc. stock performs in high volatility marketsWall Street Watch & Long-Term Safe Investment Ideas - Улправда
Will Aura Biosciences Inc. stock outperform growth indexesWall Street Watch & AI Powered Market Entry Ideas - DonanımHaber
FOMO Trade: Why Aura Biosciences Inc. stock remains on buy lists2025 Trade Ideas & Long-Term Growth Plans - DonanımHaber
BlackBerry, FedEx, Nike And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
What analyst consensus says on Aura Biosciences Inc. stock2025 Buyback Activity & Safe Entry Zone Tips - Улправда
(AURA) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Aura Biosciences, Inc. (NASDAQ:AURA) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Aura Biosciences, Inc. $AURA Stock Position Increased by B Group Inc. - Defense World
(AURA) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Rally Mode: Why Aura Biosciences Inc stock is trending among retail tradersEarnings Performance Report & Capital Efficiency Focused Strategies - moha.gov.vn
Weekly Recap: Will BWMN stock beat EPS estimatesQuarterly Profit Review & Momentum Based Trading Ideas - BỘ NỘI VỤ
Why Aura Biosciences Inc. stock is trending among retail tradersWeekly Risk Summary & Precise Swing Trade Alerts - Newser
Muscle Invasive Bladder Cancer Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | CG Oncology, Pfizer, UroGen Pharma, Janssen R&D, LLC, Protara Therapeutics, Binhui Biopharma - The Globe and Mail
Can Aura Biosciences Inc. stock outperform in 2025 bull marketWeekly Stock Recap & Daily Profit Maximizing Tips - Newser
Aura Biosciences (AURA) Stock Analysis Report | Financials & Insights - Benzinga
Aura Biosciences re-initiated with an Outperform at Evercore ISI - MSN
Market Pulse: Can Aura Biosciences Inc. stock continue upward trendPortfolio Gains Summary & AI Powered Buy and Sell Recommendations - moha.gov.vn
Evercore ISI Group Reiterates Aura Biosciences (AURA) Outperform Recommendation - MSN
What drives Aura Biosciences Inc stock priceStock Buyback Announcements & Double Or Triple Wealth - earlytimes.in
Avenzo adds CFO responsibilities to CBO Lipman’s role - BioCentury
(AURA) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
AURA Stock Receives an "Outperform" Rating from Evercore ISI Gro - GuruFocus
Evercore ISI resumes Aura Biosciences stock coverage with Outperform rating By Investing.com - Investing.com Canada
Innovative Approach and Promising Data Drive Buy Rating for Aura Biosciences - TipRanks
Aura Biosciences to Participate in the 8th Annual Evercore Healthcare Conference - The Manila Times
Aura Biosciences, Inc. (NASDAQ:AURA) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
How Aura Biosciences Inc. stock performs during Fed tightening cyclesJuly 2025 Review & Weekly High Potential Alerts - newser.com
NovaBridge subsidiary Visara appoints two key ophthalmology leaders By Investing.com - Investing.com Canada
Is Aura Biosciences Inc. stock attractive for growth ETFsEarnings Growth Report & Free Expert Verified Stock Movement Alerts - newser.com
Leerink Partnrs Has Positive Outlook of AURA FY2025 Earnings - Defense World
Aura Biosciences Inc. stock trend forecastJuly 2025 Price Swings & Consistent Growth Equity Picks - newser.com
Aura Biosciences Inc. stock outlook for YEARBuy Signal & Low Risk High Reward Ideas - newser.com
What sentiment indicators say about Aura Biosciences Inc. stockGap Down & Weekly Market Pulse Updates - newser.com
Is it time to cut losses on Aura Biosciences Inc.2025 Technical Patterns & Growth Focused Stock Pick Reports - newser.com
Why Aura Biosciences Inc. stock could see breakout soonPortfolio Gains Summary & Expert Approved Momentum Ideas - newser.com
Aura Biosciences Inc Stock (AURA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Aura Biosciences Inc Stock (AURA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hopkins Janet Jill | Chief Medical Officer |
Nov 17 '25 |
Sale |
5.42 |
17,109 |
92,731 |
252,685 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):